Acomplia, the blockbuster anti-obesity drug, performs its action by blocking cannabinoid (CB) receptors present in the brain. The CB receptors are understood to play their role in controlling food consumption and habituation. By curbing your appetite, in this manner acomplia assists you in reducing your diet and facilitating your weight loss process. Though it is very effective in reducing your weight in a very short period of time in the jumble for bottom lines and quick-fix solutions pertaining to obesity - no one has shown any concern to raise questions about the long term side effects associated with its consumption.

In reality, soon after market inception of acomplia, press reports plus independent studies suggested that side effects are slightly stronger and frequent than what is shown by the manufacturer in their clinical studies. Reports of stern depression are quite frequent too. This is attributed to the drug being active in the central nervous system, the most complex area of human physiology such that the exact degree of effects of a drug is exceedingly difficult to predict and anticipate.

A recently concluded two-year study of Acomplia also showed several side effects which include depression, anxiety. Even though the researchers stated that these side effects were generally minor and short-lived 13 percent of those involved in the trial who consumed the strongest dose of the drug, stopped taking it and dropped out of the study as a consequence of those side effects.

Other common side effects of Acomplia include dizziness, nausea, irritability, fatigue and upset stomach which occur in the initial phase, but steadily vanish with the regular use of Acomplia. Thus even though Acomplia is one of the most capable weight loss drugs available in the market still it must not be taken without the doctor’s advice. No one can provide you with better advice on Acomplia than your own physician. He may restrict you from consuming Acomplia if you suffered from some serious health problems in the past.

Also some scientist have shown their concern about the mental side effects of acomplia rimonabant and some believe that the FDA will want to cautiously study the long-rage use of the drug for possible risk factors before finally giving its approval, which could take years. Not so long ago the BBC News reported that a committee advising the US FDA has voted not to recommend the drug's approval because of concerns over suicidality, depression and other related side effects linked with usage of the drug. However, the risk benefit ratio on the consumption of acomplia is not yet established, so better alternatives can be chosen until FDA gives clearance for the drug to avoid possible side effects.